NKTT120
NKTT 120 is a humanized monoclonal antibody against the iNKT cells. NKTT 120 is promising for research of sickle cell disease (SCD) [1].
Product Specifications
UNSPSC
12352100
Target
Others
Related Pathways
Others
Field of Research
Cardiovascular Disease
References & Citations
[1]Majerus E M, et al. NKTT120 reduces iNKT cells without dose limiting toxicity in stable adult sickle cell patients in a phase 1 trial[J]. Blood, 2014, 124 (21) : 2718.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
